Key Takeaway
Naltrexone 4.5 mg capsule by MPRX, Inc. dba Medical Park Pharmacy was recalled on December 18, 2019. The hazard: Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Naltrexone 4.5 mg capsule
Description
Naltrexone 4.5 mg capsule
Hazard / Reason
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Class II: Product that may cause temporary or medically reversible health consequences.
Class II indicates the product may cause temporary or medically reversible health effects. The probability of serious harm is considered remote.
Products Affected
Naltrexone 4.5 mg capsule
DrugsCompany Information
MPRX, Inc. dba Medical Park Pharmacy
Dallas, TX, United States
View all 18 recalls by MPRX, Inc. dba Medical Park Pharmacy →Distribution
TX
Related Recalls
Squaric Acid 0.1% Topical Solution (Clinic) 30 mL
December 18, 2019
Tadalafil 6 mg Capsule
December 18, 2019
Lidocaine/Priloc/PE 15/5/0.25% 30 GM jars
December 18, 2019
Lidocaine/Priloc/PE 30/5/0.25% 30 GM jars
December 18, 2019
Sildenafil 80 mg capsules
December 18, 2019
Progesterone 200 mg Troche
December 18, 2019
Frequently Asked Questions
Is this recall still active?
Check the status badge at the top of this page. "Ongoing" means the recall is still active and you should follow the remedy instructions. "Completed" or "Terminated" means the recall process has concluded, though the safety issue remains relevant for any unrepaired products.
How do I check if my product is affected?
Compare the model number, lot code, serial number, or date range listed in the recall notice with the information on your product's label or packaging. For vehicles, check your VIN at NHTSA.gov/Recalls.
What remedy is available for this recall?
Check the remedy section above or contact the manufacturer directly for current remedy options.
Where can I find the original recall notice?
This recall was issued by FDA Drug. Visit the agency's official website for the original notice.